Lacosamide-induced excessive laughing in a patient with Lennox–Gastaut syndrome

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Lacosamide is one of the third-generation antiseizure drugs that block voltage-gated sodium channels by enhancing slow inactivation. The most common adverse effects of lacosamide include dizziness, headache, nausea, vomiting, diplopia, fatigue, and sedation. Less common side effects include memory impairment, weight gain, rash, and atrioventricular block. In this article, we describe a patient with Lennox–Gastaut syndrome who developed excessive laughing as a rare side effect of lacosamide with complete resolution after discontinuation of the medication. The present case illustrates that excessive laughing may occur as an adverse effect of lacosamide.

Cite

CITATION STYLE

APA

Algahtani, H., Shirah, B., & Algahtani, R. (2018). Lacosamide-induced excessive laughing in a patient with Lennox–Gastaut syndrome. Epilepsy and Behavior Case Reports, 10, 1–3. https://doi.org/10.1016/j.ebcr.2018.01.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free